Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.
about
Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsDiscovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate TissueATDC/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms.Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.Prostatic Adenocarcinoma With Hormone Exposure Related Changes in a Patient With Hepatic Cirrhosis - Value of Autopsy in a Case Report.PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report.Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion.Neuroendocrine tumors of the prostate.Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
P2860
Q26773613-95052F1E-34E6-4F3B-A975-62B997ADEDF8Q26997884-8DAC54C3-9237-4F3A-AF83-B2BCC504A4FDQ36342882-F997DA9C-D62A-4121-846C-7BAC67DB3775Q37156611-533A9804-E6D1-44F5-90BC-3E25E750CACFQ40656134-E7DF6818-5F5B-4D4A-AC87-298B7B712712Q41188308-FE650BBF-6ECA-4469-83BC-25DE7FBFF443Q41907553-CA8037EC-B46B-4EB1-8CEA-740223824095Q42370398-E27F746C-1B15-4E64-9685-4A36CE48CEE2Q45066002-0FD4BDC8-9B12-4626-8BEF-2BFCBFCE219DQ45978540-8C55CF21-D473-4462-9CDC-A218E5EED42BQ48087902-748E84AF-5CA0-489D-B03A-4027B46BDE6CQ49347811-8A457E64-FA5A-439D-A110-3C214BEEF088Q53045863-A87A9B20-6E7F-42D7-A7A9-8F472BD2408F
P2860
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Frequent discordance between E ...... ion-resistant prostate cancer.
@ast
Frequent discordance between E ...... ion-resistant prostate cancer.
@en
Frequent discordance between E ...... ion-resistant prostate cancer.
@nl
type
label
Frequent discordance between E ...... ion-resistant prostate cancer.
@ast
Frequent discordance between E ...... ion-resistant prostate cancer.
@en
Frequent discordance between E ...... ion-resistant prostate cancer.
@nl
prefLabel
Frequent discordance between E ...... ion-resistant prostate cancer.
@ast
Frequent discordance between E ...... ion-resistant prostate cancer.
@en
Frequent discordance between E ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Frequent discordance between E ...... tion-resistant prostate cancer
@en
P2093
Aaron M Udager
Ajjai Alva
Arul M Chinnaiyan
Javed Siddiqui
Kenneth J Pienta
Rohit Mehra
Scott A Tomlins
Xuhong Cao
P2860
P304
P356
10.1002/PROS.22836
P50
P577
2014-07-07T00:00:00Z